創毅控股(03992.HK):股份銷售已完成 要約人持股達53.51%
格隆匯7月9日丨創毅控股(03992.HK)及要約人聯合發佈公吿,股份銷售完成已於2021年7月9日落實。緊隨股份銷售完成後及於本聯合公吿日期,要約人及其一致行動人士於合共2.68億股股份中擁有權益,相當於公司全部已發行股本約53.51%。
根據收購守則規則26.1,緊隨股份銷售完成後,要約人須以現金就全部已發行股份提出強制性無條件現金要約。招商證券(香港)將按照根據收購守則將予刊發的綜合文件所載條款,代表要約人及遵照收購守則就所有無利害關係股份提出要約。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.